IN8bio Return on Tangible Equity 2020-2025 | INAB

Current and historical return on tangible equity values for IN8bio (INAB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
IN8bio Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-09-30 $-0.02B $0.01B -150.00%
2025-06-30 $-0.02B $0.02B -184.62%
2025-03-31 $-0.03B $0.01B -219.61%
2024-12-31 $-0.03B $0.01B -225.45%
2024-09-30 $-0.03B $0.01B -200.00%
2024-06-30 $-0.03B $0.01B -176.00%
2024-03-31 $-0.03B $0.02B -154.22%
2023-12-31 $-0.03B $0.03B -151.22%
2023-09-30 $-0.03B $0.02B -155.00%
2023-06-30 $-0.03B $0.02B -134.78%
2023-03-31 $-0.03B $0.02B -123.71%
2022-12-31 $-0.03B $0.02B -99.12%
2022-09-30 $-0.02B $0.03B -75.00%
2022-06-30 $-0.02B $0.03B -56.74%
2022-03-31 $-0.02B $0.03B -53.13%
2021-12-31 $-0.01B $0.04B -58.95%
2021-06-30 $-0.01B $0.01B -257.14%
2021-03-31 $-0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.010B $0.000B
IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $185.604B 15.76
Gilead Sciences (GILD) United States $177.281B 17.45
Vertex Pharmaceuticals (VRTX) United States $119.758B 30.83
Bristol Myers Squibb (BMY) United States $113.778B 8.52
GSK (GSK) United Kingdom $106.955B 11.84
Regeneron Pharmaceuticals (REGN) United States $79.352B 20.93
CSL (CSLLY) Australia $60.227B 0.00
Argenex SE (ARGX) Netherlands $51.715B 63.89
Alnylam Pharmaceuticals (ALNY) United States $44.801B 1474.39
Insmed (INSM) United States $32.840B 0.00
Biogen (BIIB) United States $26.273B 10.70
BioNTech SE (BNTX) Germany $24.518B 0.00
Royalty Pharma (RPRX) United States $24.452B 9.37
Illumina (ILMN) United States $21.565B 32.37
Genmab (GMAB) Denmark $21.372B 16.07
Incyte (INCY) United States $20.156B 19.30
Exact Sciences (EXAS) United States $19.558B 539.47
Revolution Medicines (RVMD) United States $18.783B 0.00
Moderna (MRNA) United States $16.626B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $15.571B 0.00
Roivant Sciences (ROIV) United Kingdom $15.259B 0.00
Guardant Health (GH) United States $14.482B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $13.984B 0.00
Ascendis Pharma (ASND) Denmark $13.858B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $13.172B 24.50
Exelixis (EXEL) United States $11.478B 18.37
BioMarin Pharmaceutical (BMRN) United States $11.133B 20.19
QIAGEN (QGEN) Netherlands $11.019B 20.92
Avidity Biosciences (RNA) United States $10.960B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $10.221B 0.00
Bio-Techne Corp (TECH) United States $10.167B 37.94
Jazz Pharmaceuticals (JAZZ) Ireland $10.165B 39.64
Axsome Therapeutics (AXSM) United States $9.371B 0.00
Halozyme Therapeutics (HALO) United States $8.755B 13.99
Abivax SA (ABVX) France $8.743B 0.00
Repligen (RGEN) United States $8.507B 91.04
Krystal Biotech (KRYS) United States $8.185B 42.32
Cytokinetics (CYTK) United States $7.967B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.959B 28.62
Praxis Precision Medicines (PRAX) United States $7.788B 0.00
Nuvalent (NUVL) United States $7.631B 0.00
Vaxcyte (PCVX) United States $7.514B 0.00
Rhythm Pharmaceuticals (RYTM) United States $7.274B 0.00
Cidara Therapeutics (CDTX) United States $6.960B 0.00
Merus (MRUS) Netherlands $6.826B 0.00
Belite Bio (BLTE) United States $6.502B 0.00
ImmunityBio (IBRX) United States $6.038B 0.00
PTC Therapeutics (PTCT) United States $6.012B 8.17
Alkermes (ALKS) Ireland $5.773B 16.97
Structure Therapeutics (GPCR) United States $5.451B 0.00
Kymera Therapeutics (KYMR) United States $5.441B 0.00
Cogent Biosciences (COGT) United States $5.405B 0.00
Mirum Pharmaceuticals (MIRM) United States $5.335B 0.00
Protagonist Therapeutics (PTGX) United States $5.192B 133.95
Celcuity (CELC) United States $5.152B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.890B 0.00
Zealand Pharma (ZLDPF) Denmark $4.769B 4.83
Scholar Rock Holding (SRRK) United States $4.755B 0.00
TG Therapeutics (TGTX) United States $4.633B 10.50
Immunovant (IMVT) United States $4.571B 0.00
Akero Therapeutics (AKRO) United States $4.499B 0.00
Apogee Therapeutics (APGE) United States $4.484B 0.00
Amicus Therapeutics (FOLD) United States $4.483B 357.25
ACADIA Pharmaceuticals (ACAD) United States $4.421B 37.33
CG Oncology (CGON) United States $4.383B 0.00
ADMA Biologics Inc (ADMA) United States $4.165B 29.66
GRAIL (GRAL) United States $4.041B 0.00
Arcellx (ACLX) United States $4.017B 0.00
Ligand Pharmaceuticals (LGND) United States $3.896B 95.62
Liquidia (LQDA) United States $3.846B 0.00
Anbio Biotechnology (NNNN) Germany $3.548B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.386B 99.27
Viking Therapeutics (VKTX) United States $3.382B 0.00
Denali Therapeutics (DNLI) United States $3.335B 0.00
Terns Pharmaceuticals (TERN) United States $3.317B 0.00
Erasca (ERAS) United States $3.285B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.203B 0.00
Viridian Therapeutics (VRDN) United States $3.169B 0.00
Legend Biotech (LEGN) United States $3.167B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.132B 0.00
Edgewise Therapeutics (EWTX) United States $3.059B 0.00
Disc Medicine (IRON) United States $3.045B 0.00
IDEAYA Biosciences (IDYA) United States $2.986B 0.00
Travere Therapeutics (TVTX) United States $2.961B 0.00
Vera Therapeutics (VERA) United States $2.895B 0.00
Apellis Pharmaceuticals (APLS) United States $2.889B 73.64
Twist Bioscience (TWST) United States $2.868B 0.00
Beam Therapeutics (BEAM) United States $2.833B 0.00
Adaptive Biotechnologies (ADPT) United States $2.808B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.799B 0.00
Alumis (ALMS) United States $2.758B 0.00
Spyre Therapeutics (SYRE) United States $2.541B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.540B 0.00
Telix Pharmaceuticals (TLX) Australia $2.517B 0.00
Mineralys Therapeutics (MLYS) United States $2.443B 0.00
Bavarian Nordic (BVNRY) Denmark $2.432B 6.60
Immunome (IMNM) United States $2.397B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.389B 0.00
Arcus Biosciences (RCUS) United States $2.339B 0.00
Dianthus Therapeutics (DNTH) United States $2.299B 0.00
WAVE Life Sciences (WVE) Singapore $2.245B 0.00
Maze Therapeutics (MAZE) United States $2.239B 0.00
Mesoblast (MESO) Australia $2.218B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.179B 11.90
Recursion Pharmaceuticals (RXRX) United States $2.173B 0.00
Sarepta Therapeutics (SRPT) United States $2.171B 0.00
Ascentage Pharma Group - (AAPG) China $2.162B 0.00
Sionna Therapeutics (SION) United States $1.948B 0.00
Nuvation Bio (NUVB) United States $1.930B 0.00
Vericel (VCEL) United States $1.868B 153.92
Syndax Pharmaceuticals (SNDX) United States $1.856B 0.00
MannKind (MNKD) United States $1.845B 60.10
Zai Lab (ZLAB) China $1.825B 0.00
Dynavax Technologies (DVAX) United States $1.819B 53.41
ANI Pharmaceuticals (ANIP) United States $1.798B 13.94
Olema Pharmaceuticals (OLMA) United States $1.761B 0.00
Stoke Therapeutics (STOK) United States $1.757B 45.92
Corvus Pharmaceuticals (CRVS) United States $1.757B 0.00
MBX Biosciences (MBX) United States $1.754B 0.00
Zymeworks (ZYME) United States $1.734B 0.00
Precigen (PGEN) United States $1.709B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.670B 0.00
Tyra Biosciences (TYRA) United States $1.656B 0.00
Agios Pharmaceuticals (AGIO) United States $1.642B 0.00
Celldex Therapeutics (CLDX) United States $1.639B 0.00
Upstream Bio (UPB) United States $1.618B 0.00
Tango Therapeutics (TNGX) United States $1.608B 0.00
Alvotech (ALVO) Luxembourg $1.604B 23.13
Rapt Therapeutics (RAPT) United States $1.598B 0.00
NeoGenomics (NEO) United States $1.593B 0.00
Fortrea Holdings (FTRE) United States $1.558B 33.06
UniQure (QURE) Netherlands $1.539B 0.00
Oculis Holding AG (OCS) Switzerland $1.520B 0.00
Intellia Therapeutics (NTLA) United States $1.513B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.480B 0.00
Novavax (NVAX) United States $1.412B 3.59
Trevi Therapeutics (TRVI) United States $1.405B 0.00
AnaptysBio (ANAB) United States $1.399B 0.00
AtaiBeckley Inc (ATAI) Netherlands $1.395B 0.00
NovoCure (NVCR) Jersey $1.365B 0.00
Monte Rosa Therapeutics (GLUE) United States $1.360B 65.25
Rapport Therapeutics (RAPP) United States $1.323B 0.00
Certara (CERT) United States $1.322B 24.41
Nurix Therapeutics (NRIX) United States $1.314B 0.00
Kodiak Sciences (KOD) United States $1.279B 0.00
Biohaven (BHVN) United States $1.244B 0.00
Sana Biotechnology (SANA) United States $1.223B 0.00
Oxford BioMedica (OXBDF) United Kingdom $1.216B 0.00
Immatics (IMTX) Germany $1.214B 0.00
Inhibrx Biosciences (INBX) United States $1.196B 0.00
Pharming Group (PHAR) Netherlands $1.191B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.181B 0.00
Compass Therapeutics (CMPX) United States $1.160B 0.00
Castle Biosciences (CSTL) United States $1.152B 157.88
Septerna (SEPN) United States $1.121B 0.00
EyePoint (EYPT) United States $1.100B 0.00
Oric Pharmaceuticals (ORIC) United States $1.087B 0.00
Vir Biotechnology (VIR) United States $1.073B 0.00
AbCellera Biologics (ABCL) Canada $1.048B 0.00
Iovance Biotherapeutics (IOVA) United States $1.036B 0.00
Nanobiotix S.A - (NBTX) France $1.034B 0.00
CytomX Therapeutics (CTMX) United States $1.032B 15.23
MoonLake Immunotherapeutics (MLTX) Switzerland $1.014B 0.00
Ventyx Biosciences (VTYX) United States $0.996B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.986B 0.00
Geron (GERN) United States $0.983B 0.00
Zenas BioPharma (ZBIO) United States $0.974B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.962B 0.00
Palvella Therapeutics (PVLA) United States $0.946B 0.00
ArriVent BioPharma (AVBP) United States $0.936B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.935B 0.00
CureVac (CVAC) Germany $0.927B 0.00
Urogen Pharma (URGN) United States $0.922B 0.00
Bicara Therapeutics (BCAX) United States $0.918B 0.00
Pacira BioSciences (PCRX) United States $0.913B 10.45
Arvinas (ARVN) United States $0.888B 0.00
DBV Technologies S.A (DBVT) France $0.867B 0.00
Inventiva S.A (IVA) France $0.863B 0.00
Arbutus Biopharma (ABUS) United States $0.844B 0.00
Janux Therapeutics (JANX) United States $0.841B 0.00
GH Research (GHRS) Ireland $0.823B 0.00
Jade Biosciences (JBIO) United States $0.821B 0.00
MapLight Therapeutics (MPLT) United States $0.814B 0.00
YD Bio (YDES) $0.809B 0.00
Gyre Therapeutics (GYRE) United States $0.791B 102.62
Bright Minds Biosciences (DRUG) United States $0.765B 0.00
Annexon (ANNX) United States $0.763B 0.00
MiMedx (MDXG) United States $0.754B 13.40
Cullinan Therapeutics (CGEM) United States $0.751B 0.00
BioAge Labs (BIOA) United States $0.721B 0.00
Kura Oncology (KURA) United States $0.720B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
Prime Medicine (PRME) United States $0.686B 0.00
EnGene Holdings (ENGN) Canada $0.670B 0.00
Cytek Biosciences (CTKB) United States $0.660B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
CorMedix Inc (CRMD) United States $0.644B 5.96
MeiraGTx Holdings (MGTX) United States $0.630B 0.00
Emergent Biosolutions (EBS) United States $0.615B 5.91
Evommune (EVMN) United States $0.606B 0.00
Design Therapeutics (DSGN) United States $0.593B 0.00
Fulcrum Therapeutics (FULC) United States $0.580B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.580B 0.00
Gossamer Bio (GOSS) United States $0.574B 0.00
SELLAS Life Sciences (SLS) United States $0.566B 0.00
Keros Therapeutics (KROS) United States $0.561B 11.95
Ginkgo Bioworks Holdings (DNA) United States $0.555B 0.00
Replimune (REPL) United States $0.547B 0.00
REGENXBIO (RGNX) United States $0.546B 0.00
LENZ Therapeutics (LENZ) United States $0.510B 0.00
Myriad Genetics (MYGN) United States $0.510B 0.00
Solid Biosciences (SLDB) United States $0.501B 0.00
Alto Neuroscience (ANRO) United States $0.491B 0.00
Niagen Bioscience (NAGE) United States $0.486B 38.06
ADC Therapeutics SA (ADCT) Switzerland $0.483B 0.00
Prothena (PRTA) Ireland $0.480B 0.00
Kamada (KMDA) Israel $0.474B 22.89
Northwest Biotherapeutics (NWBO) United States $0.463B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.457B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.454B 0.00
Absci (ABSI) United States $0.454B 0.00
Entrada Therapeutics (TRDA) United States $0.453B 0.00
PureTech Health (PRTC) United States $0.452B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.450B 0.00
Ocugen (OCGN) United States $0.447B 0.00
Greenwich LifeSciences (GLSI) United States $0.443B 0.00
Monopar Therapeutics (MNPR) United States $0.438B 0.00
Forte Biosciences (FBRX) United States $0.432B 0.00
Benitec Biopharma (BNTC) United States $0.427B 0.00
DiaMedica Therapeutics (DMAC) United States $0.426B 0.00
Tectonic Therapeutic (TECX) United States $0.421B 0.00
Prima BioMed (IMMP) Australia $0.421B 0.00
Allogene Therapeutics (ALLO) United States $0.420B 0.00
Contineum Therapeutics (CTNM) United States $0.420B 0.00
Verastem (VSTM) United States $0.417B 0.00
Eton Pharmaceuticals (ETON) United States $0.407B 0.00
Invivyd (IVVD) United States $0.406B 0.00
Anavex Life Sciences (AVXL) United States $0.404B 0.00
NovaBridge Biosciences (NBP) United States $0.395B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.383B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.377B 0.00
Zura Bio (ZURA) United States $0.375B 0.00
Aura Biosciences (AURA) United States $0.373B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.367B 0.00
Kyverna Therapeutics (KYTX) United States $0.365B 0.00
PepGen (PEPG) United States $0.349B 0.00
X4 Pharmaceuticals (XFOR) United States $0.348B 0.00
Puma Biotechnology (PBYI) United States $0.344B 9.22
Adlai Nortye (ANL) Cayman Islands $0.342B 0.00
GENFIT S.A (GNFTY) France $0.338B 0.00
Neumora Therapeutics (NMRA) United States $0.331B 0.00
Foghorn Therapeutics (FHTX) United States $0.331B 0.00
Immix Biopharma (IMMX) United States $0.329B 0.00
AC Immune (ACIU) Switzerland $0.328B 0.00
XOMA Royalty (XOMA) United States $0.328B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.327B 0.00
Climb Bio (CLYM) United States $0.323B 0.00
Candel Therapeutics (CADL) United States $0.322B 0.00
Lifecore Biomedical (LFCR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.318B 0.00
Amarin (AMRN) Ireland $0.312B 0.00
Immuneering (IMRX) United States $0.311B 0.00
Rezolute (RZLT) United States $0.300B 0.00
Aardvark Therapeutics (AARD) United States $0.290B 0.00
BGM Group (BGM) China $0.286B 0.00
Neurogene (NGNE) United States $0.284B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.280B 4.58
Adherex Technologies (FENC) United States $0.268B 0.00
Coherus Oncology (CHRS) United States $0.262B 0.00
Nautilus Biotechnology (NAUT) United States $0.254B 0.00
Shattuck Labs (STTK) United States $0.244B 0.00
Cabaletta Bio (CABA) United States $0.241B 0.00
Palisade Bio (PALI) United States $0.240B 0.00
Adocia (ADOCY) France $0.231B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.227B 0.00
Voyager Therapeutics (VYGR) United States $0.222B 0.00
Alector (ALEC) United States $0.217B 0.00
Nuvectis Pharma (NVCT) United States $0.214B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.209B 0.00
SAB Biotherapeutics (SABS) United States $0.209B 0.00
Tharimmune (THAR) United States $0.207B 0.00
Sagimet Biosciences (SGMT) United States $0.203B 0.00
Editas Medicine (EDIT) United States $0.196B 0.00
Sangamo Therapeutics (SGMO) United States $0.191B 0.00
Humacyte (HUMA) United States $0.191B 0.00
Molecular Partners AG (MOLN) Switzerland $0.185B 0.00
Jyong Biotech (MENS) Taiwan $0.182B 0.00
C4 Therapeutics (CCCC) United States $0.182B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.181B 0.00
CAMP4 Therapeutics (CAMP) United States $0.177B 0.00
Cartesian Therapeutics (RNAC) United States $0.177B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.171B 0.00
Innate Pharma S.A (IPHA) France $0.171B 0.00
Kalaris Therapeutics (KLRS) United States $0.170B 0.00
Satellos Bioscience (MSLE) Canada $0.168B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.167B 0.00
Alps Group (ALPS) United States $0.164B 2.98
ProQR Therapeutics (PRQR) Netherlands $0.163B 0.00
Opus Genetics (IRD) United States $0.160B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.157B 0.00
Nkarta (NKTX) United States $0.153B 0.00
VTv Therapeutics (VTVT) United States $0.151B 0.00
Tenaya Therapeutics (TNYA) United States $0.150B 0.00
Rani Therapeutics Holdings (RANI) United States $0.146B 0.00
Mersana Therapeutics (MRSN) United States $0.145B 0.00
Black Diamond Therapeutics (BDTX) United States $0.145B 7.06
Fate Therapeutics (FATE) United States $0.142B 0.00
Elicio Therapeutics (ELTX) United States $0.142B 0.00
Anika Therapeutics (ANIK) United States $0.139B 0.00
Adagene (ADAG) China $0.139B 0.00
Connect Biopharma Holdings (CNTB) United States $0.138B 0.00
Seres Therapeutics (MCRB) United States $0.137B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.137B 0.00
Caribou Biosciences (CRBU) United States $0.136B 0.00
Crescent Biopharma (CBIO) United States $0.136B 0.00
Whitehawk Therapeutics (WHWK) United States $0.136B 0.00
Vor Biopharma (VOR) $0.133B 0.00
Codexis (CDXS) United States $0.130B 0.00
Sutro Biopharma (STRO) United States $0.129B 0.00
Alpha Teknova (TKNO) United States $0.127B 0.00
Spero Therapeutics (SPRO) United States $0.126B 0.00
Turn Therapeutics (TTRX) United States $0.123B 0.00
Actuate Therapeutics (ACTU) United States $0.117B 0.00
Cardiff Oncology (CRDF) United States $0.115B 0.00
Repare Therapeutics (RPTX) Canada $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
Starpharma Holdings (SPHRY) Australia $0.110B 0.00
Ovid Therapeutics (OVID) United States $0.108B 0.00
Alpha Cognition (ACOG) Canada $0.107B 0.00
Genelux (GNLX) United States $0.104B 0.00
Oncolytics Biotech (ONCY) Canada $0.103B 0.00
Artiva Biotherapeutics (ARTV) United States $0.103B 0.00
Seer (SEER) United States $0.101B 0.00
Cognition Therapeutics (CGTX) United States $0.101B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
Fortress Biotech (FBIO) United States $0.098B 0.00
Agenus (AGEN) United States $0.097B 0.00
Chrome Holding (MEHCQ) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
Citius Oncology (CTOR) United States $0.095B 0.00
ATyr Pharma (ATYR) United States $0.095B 0.00
MaxCyte (MXCT) United States $0.093B 0.00
Equillium (EQ) United States $0.092B 0.00
ALX Oncology Holdings (ALXO) United States $0.091B 0.00
BioStem Technologies (BSEM) $0.090B 6.32
EXoZymes (EXOZ) United States $0.090B 0.00
Spruce Biosciences (SPRB) United States $0.083B 0.00
MediciNova (MNOV) United States $0.082B 0.00
Tenax Therapeutics (TENX) United States $0.081B 0.00
ImageneBio (IMA) United States $0.079B 0.00
BioHarvest Sciences (BHST) Canada $0.079B 0.00
Immunic (IMUX) United States $0.079B 0.00
OKYO Pharma (OKYO) $0.079B 0.00
Biomea Fusion (BMEA) United States $0.078B 0.00
Scilex Holding (SCLX) United States $0.078B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
XBiotech (XBIT) United States $0.076B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.076B 0.00
Pliant Therapeutics (PLRX) United States $0.073B 0.00
Annovis Bio (ANVS) United States $0.072B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.069B 0.00
InflaRx (IFRX) Germany $0.065B 0.00
BeyondSpring (BYSI) United States $0.063B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Radiopharm Theranostics - (RADX) Australia $0.061B 0.00
Tevogen Bio Holdings (TVGN) United States $0.059B 0.00
Grace Therapeutics (GRCE) United States $0.058B 0.00
TScan Therapeutics (TCRX) United States $0.058B 0.00
MiNK Therapeutics (INKT) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
IBio (IBIO) United States $0.052B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.051B 0.00
Q32 Bio (QTTB) United States $0.049B 0.00
Aligos Therapeutics (ALGS) United States $0.049B 0.00
Instil Bio (TIL) United States $0.049B 0.00
ABVC BioPharma (ABVC) United States $0.046B 0.00
Cingulate (CING) United States $0.046B 0.00
CervoMed (CRVO) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.044B 0.00
Clene (CLNN) United States $0.044B 0.00
Galecto (GLTO) Denmark $0.044B 0.00
Elutia (ELUT) United States $0.044B 0.00
INmune Bio (INMB) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Jasper Therapeutics (JSPR) United States $0.041B 0.00
PDS Biotechnology (PDSB) United States $0.040B 0.00
Lisata Therapeutics (LSTA) United States $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.040B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.039B 0.00
Passage Bio (PASG) United States $0.038B 0.00
NextCure (NXTC) United States $0.038B 0.00
TELA Bio (TELA) United States $0.038B 0.00
Generation Bio (GBIO) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.037B 0.00
Atara Biotherapeutics (ATRA) United States $0.036B 2.31
Celularity (CELU) United States $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
BioXcel Therapeutics (BTAI) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Rein Therapeutics (RNTX) United States $0.034B 0.00
Hyperion DeFi (HYPD) United States $0.034B 0.00
Pluri (PLUR) Israel $0.033B 0.00
Kyntra Bio Inc (KYNB) United States $0.033B 0.00
Werewolf Therapeutics (HOWL) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
BRIACELL THERAP (BCTX) Canada $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Medicus Pharma (MDCX) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Skye Bioscience (SKYE) United States $0.030B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.030B 0.00
Rallybio (RLYB) United States $0.028B 0.00
Aytu BioPharma (AYTU) United States $0.028B 0.00
Alterity Therapeutics - (ATHE) Australia $0.028B 0.00
Exicure (XCUR) United States $0.027B 0.00
Cue Biopharma (CUE) United States $0.027B 0.00
Athira Pharma (ATHA) United States $0.027B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.027B 0.00
TuHURA Biosciences (HURA) United States $0.027B 0.00
Senti Biosciences (SNTI) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Apollomics (APLM) United States $0.024B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.024B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Intensity Therapeutics (INTS) United States $0.022B 0.00
Neuphoria Therapeutics (NEUP) United States $0.022B 0.00
IO Biotech (IOBT) Denmark $0.020B 0.00
Lexaria Bioscience (LEXX) Canada $0.020B 0.00
Pasithea Therapeutics (KTTA) United States $0.020B 0.00
FibroBiologics (FBLG) United States $0.019B 0.00
Genenta Science S.p.A (GNTA) Italy $0.019B 0.00
LeonaBio (LONA) United States $0.018B 0.00
Black Titan (BTTC) United States $0.017B 0.00
Quantum Biopharma (QNTM) Canada $0.016B 0.00
Polyrizon (PLRZ) Israel $0.016B 0.00
Cadrenal Therapeutics (CVKD) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Applied Therapeutics (APLT) United States $0.014B 0.00
Hoth Therapeutics (HOTH) United States $0.014B 0.00
Cocrystal Pharma (COCP) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
NewcelX (NCEL) Switzerland $0.013B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Longeveron (LGVN) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Curis (CRIS) United States $0.011B 0.00
BioAtla (BCAB) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Edesa Biotech (EDSA) Canada $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Quince Therapeutics (QNCX) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
CalciMedica (CALC) United States $0.010B 0.00
Beyond Air (XAIR) United States $0.009B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Purple Biotech (PPBT) Israel $0.008B 0.00
Aptevo Therapeutics (APVO) United States $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Dogwood Therapeutics (DWTX) United States $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Advanced Biomed (ADVB) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Dermata Therapeutics (DRMA) United States $0.006B 0.00
BioAffinity Technologies (BIAF) United States $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.006B 0.00
Evogene (EVGN) Israel $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Aprea Therapeutics (APRE) United States $0.005B 0.00
Abpro Holdings (ABP) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
MetaVia (MTVA) United States $0.005B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
HCW Biologics (HCWB) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Arcadia Biosciences (RKDA) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Enveric Biosciences (ENVB) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
AstraZeneca (AZN) United Kingdom $0.000B 0.00
Compugen (CGEN) Israel $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00